Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pSLCAR-CD19-28z Citations (1)

Originally described in: A High-Throughput Method for Characterizing Novel Chimeric Antigen Receptors in Jurkat Cells.
Bloemberg D, Nguyen T, MacLean S, Zafer A, Gadoury C, Gurnani K, Chattopadhyay A, Ash J, Lippens J, Harcus D, Page M, Fortin A, Pon RA, Gilbert R, Marcil A, Weeratna RD, McComb S Mol Ther Methods Clin Dev. 2020 Jan 31;16:238-254. doi: 10.1016/j.omtm.2020.01.012. eCollection 2020 Mar 13.
PubMed Journal

Articles Citing pSLCAR-CD19-28z

Articles
In situ PEGylation of CAR T cells alleviates cytokine release syndrome and neurotoxicity. Gong N, Han X, Xue L, El-Mayta R, Metzloff AE, Billingsley MM, Hamilton AG, Mitchell MJ. Nat Mater. 2023 Dec;22(12):1571-1580. doi: 10.1038/s41563-023-01646-6. Epub 2023 Sep 11. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.